Toggle navigation
Browse
Home
Researchers
Research Departments
Publications
About/Support
Phase 2 placebo-controlled, double-blind trial of dasatinib added to gemcitabine for patients with locally-advanced pancreatic cancer
Article
Industry Collaboration
International Collaboration
Overview
Research
Additional Document Info
View All
Overview
cited authors
Evans, T. R. J.; Van Cutsem, E.; Moore, M. J.; Bazin, I. S.; Rosemurgy, A.; Bodoky, G.; Deplanque, G.; Harrison, M.; Melichar, B.; Pezet, D.; Elekes, A.; Rock, E.; Lin, C.; Strauss, L.; O'Dwyer, P. J.
Publication Date
February 1, 2017
webpage
Web of Science
published in
ANNALS OF ONCOLOGY
Journal
Research
category
ONCOLOGY
Web of Science Category
keywords
anticancer therapy
dasatinib
gemcitabine
pancreatic cancer
Additional Document Info
start page
354
end page
361
volume
28
issue
2